Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Krsnaa Diagnostics runs a network of diagnostic centers across India, providing radiology scans and pathology tests to patients, governments, hospitals, and clinics.
Krsnaa Diagnostics is a healthcare company that runs a large network of diagnostic centers across India. If you need an X-ray, an MRI, a CT scan, or a blood test, Krsnaa is one of the companies that operates the machines and labs that produce those results. It sells its services to three main types of customers: government health schemes, hospitals that outsource their diagnostic work, and private patients who walk in.
The business model is built around public-private partnerships. Many Indian state governments want to offer free or cheap diagnostic scans to citizens, especially in poorer and rural areas, but they don't want to own and run the equipment themselves. So they hand the job to companies like Krsnaa. Krsnaa sets up centers, often inside government hospitals or in remote districts, and gets paid per test or per scan. It also does a similar job for private hospitals and clinics that want to offer diagnostics without building their own labs. The big attraction for customers is cost and reach: Krsnaa can offer scans at prices well below what a standalone private center would charge, because it runs high volumes and keeps equipment busy across many locations. This makes Krsnaa a volume business more than a brand business. Its revenue comes from the sheer number of tests it performs and the contracts it wins with state governments. That gives it a long runway — India's public health system still has limited diagnostic capacity, and governments keep tendering out these services. But it also makes Krsnaa dependent on winning and keeping government contracts, which can be slow to sign, price-sensitive, and exposed to payment delays from public bodies. It competes with other diagnostic chains and with hospitals that do their own in-house testing.
The company's edge is its ability to set up and run centers in places where private operators don't bother to go, using a standardized, low-cost operating model. That reach is hard to copy quickly, and it fits neatly with government priorities around rural healthcare access. The main risk is exactly what makes the model work: heavy reliance on government customers. If a state changes its policy, delays payments, or re-tenders a contract, Krsnaa feels it. For investors, this is a bet on India's public health spending and on Krsnaa's ability to keep winning those contracts while expanding into new states.
Saved answer · last researched 16 Nov 2026